+44 (0)1865 595230 nac.contact@lgcgroup.com
0 Items
Select Page

Immunoassays

Showing all 8 results

  • SARS-CoV-2 Omicron Variant Neutralization

    SARS-CoV-2 Neutralization Assay Development Kit (Brazilian Variant RBD-ACE2)

    BRAZILIAN VARIANT This SARS-CoV-2 Neutralization Assay Development Kit (BZ variant RBD-ACE2) is intended for the identification and qualitative measurement of neutralizing antibodies. Kit contains enough reagents for 10 x 96-well plates. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.

    Full product information

    $2,904.70 excl. VAT

  • SARS-CoV-2 Lambda Variant Neutralization

    SARS-CoV-2 Neutralization Assay Development Kit (Delta Variant RBD-ACE2)

    DELTA VARIANT This SARS-CoV-2 Neutralization Assay Development Kit (Delta variant RBD-ACE2) is intended for the identification and qualitative measurement of neutralizing antibodies. Kit contains enough reagents for 10 x 96-well plates. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.

    Full product information

    $2,904.70 excl. VAT

  • SARS-CoV-2 Omicron Variant Neutralization

    SARS-CoV-2 Neutralization Assay Development Kit (Kerala Variant RBD-ACE2)

    KERALA (KAPPA/B.1.617.1) VARIANT This SARS-CoV-2 Neutralization Assay Development Kit (Kerala variant RBD-ACE2) is intended for the identification and qualitative measurement of neutralizing antibodies. Kit contains enough reagents for 10 x 96-well plates. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.

    Full product information

    $2,904.70 excl. VAT

  • SARS-CoV-2 Lambda Variant Neutralization

    SARS-CoV-2 Neutralization Assay Development Kit (Lambda Variant RBD-ACE2)

    LAMBDA VARIANT This SARS-CoV-2 Neutralization Assay Development Kit (Lambda variant RBD-ACE2) is intended for the identification and qualitative measurement of neutralizing antibodies. Kit contains enough reagents for 10 x 96-well plates. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.

    Full product information

    $2,904.70 excl. VAT

  • SARS-CoV-2 Omicron Variant Neutralization

    SARS-CoV-2 Neutralization Assay Development Kit (RBD-ACE2)

    Wild-Type (Wuhan-Hu-1) This SARS-CoV-2 Neutralization Assay Development Kit (RBD-ACE2) is intended for the identification and qualitative measurement of neutralizing antibodies. Kit contains enough reagents for 10 x 96-well plates. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.

    Full product information

    $2,904.70 excl. VAT

  • SARS-CoV-2 Omicron Variant Neutralization

    SARS-CoV-2 Neutralization Assay Development Kit (South African Variant RBD-ACE2)

    SOUTH AFRICAN VARIANT This SARS-CoV-2 Neutralization Assay Development Kit (SA variant RBD-ACE2) is intended for the identification and qualitative measurement of neutralizing antibodies. Kit contains enough reagents for 10 x 96-well plates. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.

    Full product information

    $2,904.70 excl. VAT

  • SARS-CoV-2 Omicron Variant Neutralization

    SARS-CoV-2 Neutralization Assay Development Kit (United Kingdom Variant RBD-ACE2)

    UNITED KINGDOM (UK) VARIANT This SARS-CoV-2 Neutralization Assay Development Kit (UK variant RBD-ACE2) is intended for the identification and qualitative measurement of neutralizing antibodies. Kit contains enough reagents for 10 x 96-well plates. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.

    Full product information

    $2,904.70 excl. VAT

  • Zika Antibody Assay Kit

    Zika Virus Total Antibody Detection Assay Development Kit

    The Native Antigen Company Zika virus total antibody assay development kit is designed to aid in the development of assays for the detection of Zika-specific antibodies in human serum. It is minimally cross-reactive with antibodies to Dengue virus (a closely-related flavivirus), and so can be used to develop assays which can distinguish human anti-Zika antibodies from other flavivirus and infectious disease antibodies, especially in epidemiological studies. Use of a Zika antibody assay is intended for detection of IgG in convalescent sera, although IgM/IgA are also detected earlier on in the infection cycle.

    Full product information

    $771.90 excl. VAT